2010 Cannabinoids Epilepsy 
Project CBD
MARCH 21, 2023
While animal studies have revealed that cannabinoid receptors likely have a role in modulating auditory signaling, there is no compelling data either from animal or human studies for the use of cannabinoids to alleviate tinnitus.” And its conclusion? While the collective evidence to date is mixed and inconclusive, it’s also incomplete.
Cannabis Law Report
JANUARY 15, 2019
British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 3, 2021
It includes tetrahydrocannabinol, cannabis oil, and other cannabinoids. Many western countries have allowed using these Cannabis oils as a medicine to cure serve epilepsy and related diseases. However, it contains an equivalent blend of THC and Cannabis oil yet would not be appropriate for treating youngsters with epilepsy like Billy.
Miss Marijuana
MAY 9, 2021
Today we will take an in-depth look at the effects, benefits, and uses of three cannabinoids: CBD, CBN, and CBG. Cannabidiol, also known as CBD, is one of the two most essential cannabinoid components of the cannabis plant, found in varying proportions depending on the strain. CBG is one of the many cannabinoids in cannabis and hemp.
CannaMD
AUGUST 8, 2020
In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system.
Alchimia
JUNE 20, 2016
CBD is a cannabinoid present in cannabis plants with a very similar molecular structure to THC but without any kind of psychoactive effect. It has been demonstrated that CBD has low affinity with the CB1 and CB2 cannabinoid receptors , but it does act on other receptors of the human body like GPR55 or 5-HT1A. What is CBD?
Cannabis Law Report
SEPTEMBER 23, 2019
Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use.
Expert insights. Personalized for you.
144 
Let's personalize your content